Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL

Watchlist Manager
Zentalis Pharmaceuticals Inc Logo
Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
Watchlist
Price: 3.18 USD 1.6%
Market Cap: 226.1m USD
Have any thoughts about
Zentalis Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

ZNTL Price Targets Summary
Zentalis Pharmaceuticals Inc

Wall Street analysts forecast ZNTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZNTL is 9.69 USD with a low forecast of 4.04 USD and a high forecast of 21 USD.

Lowest
Price Target
4.04 USD
27% Upside
Average
Price Target
9.69 USD
205% Upside
Highest
Price Target
21 USD
560% Upside

ZNTL Last Price Targets
Zentalis Pharmaceuticals Inc

The latest public price target was made on Jun 18, 2024 by Robert Driscoll from Wedbush , who expects ZNTL stock to rise by 26% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Robert Driscoll
Wedbush
4 USD
Upside 26%
5 months ago
Jun 18, 2024
Wedbush downgrades Zentalis to Underperform on unclear azeno path forward
TheFly
Matthew Harrison
Morgan Stanley
8 USD
Upside 152%
5 months ago
Jun 18, 2024
Morgan Stanley Downgrades Zentalis Pharmaceuticals (ZNTL) to Equalweight
StreetInsider
Bradley Canino
Stifel Nicolaus
10 USD
Upside 214%
5 months ago
Jun 18, 2024
Zentalis price target lowered to $10 from $32 at Stifel
TheFly
Akash Tewari
Jefferies
6 USD
Upside 89%
5 months ago
Jun 18, 2024
Zentalis downgraded to Hold from Buy at Jefferies
TheFly
Bradley Canino
Stifel Nicolaus
32 USD
Upside 906%
6 months ago
May 7, 2024
Zentalis Pharmaceuticals (ZNTL) PT Lowered to $32 at Stifel
StreetInsider
Robert Driscoll
Wedbush
Price Target 4 USD
Upside/Downside 26%
View Source
Matthew Harrison
Morgan Stanley
Price Target 8 USD
Upside/Downside 152%
View Source
Bradley Canino
Stifel Nicolaus
Price Target 10 USD
Upside/Downside 214%
View Source
Akash Tewari
Jefferies
Price Target 6 USD
Upside/Downside 89%
View Source
Bradley Canino
Stifel Nicolaus
Price Target 32 USD
Upside/Downside 906%
View Source
Zentalis Pharmaceuticals Inc Competitors:
Price Targets
DSGN
Design Therapeutics Inc
53% Upside
BMRN
Biomarin Pharmaceutical Inc
55% Upside
ZYME
Zymeworks Inc
23% Upside
6955
Shandong Boan Biotechnology Co Ltd
43% Upside
BCAB
Bioatla Inc
531% Upside
IONS
Ionis Pharmaceuticals Inc
80% Upside
7774
Japan Tissue Engineering Co Ltd
147% Upside
STRO
Sutro Biopharma Inc
376% Upside

Revenue
Forecast

Revenue Estimate
Zentalis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Zentalis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Zentalis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZNTL's stock price target?
Price Target
9.69 USD

According to Wall Street analysts, the average 1-year price target for ZNTL is 9.69 USD with a low forecast of 4.04 USD and a high forecast of 21 USD.

Back to Top